PIONEER virtual General Assembly Meeting Nov 2020 – join us at the halfway point of the project
Read morePIONEER convened its Annual General Assembly Meeting virtually on November 23rd and 24th, with over 60 members gathering online to report on the progress of their work packages and to exchange ideas. Discussion were focused on prioritisation of datasets...
OnFocus Podcast How Big Data Is Helping To Answer Questions About Prostate Cancer
Read moreSusan Evans Axelsson (PIONEER WP3) joins Clare Delmar from the Focal Therapy Clinic (prospective PIONEER data contributor) for OnFocus, a podcast series discussing the little known, less understood and often ignored issues facing men diagnosed with prostate cancer. For...
Calling all patients: What Outcomes are important for men with advanced prostate cancer?
Read moreCalling all patients: What Outcomes are important for men with advanced prostate cancer? An interview study Are you an advanced prostate cancer patient? Are you currently receiving, or have received in the past, either ADT or Chemotherapy treatment since...
First Data Sharing Agreement Signed
Read moreFirst Data Sharing Agreement signed with external data contributor Active Biotech AB. Active Biotech AB has now shared data collected in a phase 3 randomised, double blind, placebo controlled study of tasquinimod in men with metastatic castrate-resistant prostate cancer....
Contact us here
PIONEER is funded through the IMI2 Joint Undertaking and is listed under grant agreement No. 777492. IMI2 receives support from the European Union’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
